Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.
暂无分享,去创建一个
D A Isenberg | D. Isenberg | A. Jones | S. Rauz | S. Bowman | N. Sutcliffe | E. Price | J. Hamburger | A Jones | S J Bowman | N Sutcliffe | F Goldblatt | M Adler | E Price | A Canavan | J Hamburger | A Richards | S Rauz | M Regan | K Gadsby | S Rigby | R Mathew | D Mulherin | A Stevenson | P Nightingale | M. Regan | F. Goldblatt | D. Mulherin | K. Gadsby | A. Richards | P. Nightingale | S. Rigby | M. Adler | A. Stevenson | A. Canavan | R. Mathew | S. Bowman
[1] D. Isenberg,et al. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. , 2005, Rheumatology.
[2] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .
[3] F. Vivino,et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. , 1999, Archives of internal medicine.
[4] S. Bowman,et al. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. , 2003, The Journal of rheumatology.
[5] P. Vermersch,et al. Neurologic Manifestations in Primary Sjögren Syndrome: A Study of 82 Patients , 2004, Medicine.
[6] D. Cella,et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. , 1997, Journal of pain and symptom management.
[7] Sheila M. Williams,et al. The Xerostomia Inventory: a multi-item approach to measuring dry mouth. , 1999, Community dental health.
[8] R. Jonsson,et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.
[9] R. Schiffman,et al. Reliability and validity of the Ocular Surface Disease Index. , 2000, Archives of ophthalmology.
[10] D. Isenberg,et al. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. , 2006, Rheumatology.
[11] S. Bowman,et al. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. , 2004, Rheumatology.
[12] M. Dougados,et al. Development of classification and response criteria for rheumatic diseases. , 2006, Arthritis and rheumatism.
[13] M. R. Visser,et al. Fatigue in primary Sjögren’s syndrome , 1998, Annals of the rheumatic diseases.
[14] A. van der Heide,et al. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial. , 1993, Annals of the rheumatic diseases.
[15] R. Jonsson,et al. Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK. , 2001, Rheumatology.
[16] D A Isenberg,et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.
[17] R. Fox,et al. Sjögren's syndrome , 1995, The Lancet.
[18] C. Gordon,et al. Definition and treatment of lupus flares measured by the BILAG index. , 2003, Rheumatology.
[19] A. Vissink,et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. , 2005, Arthritis and rheumatism.
[20] John E. Ware,et al. SF-36 Health Survey. , 1990 .
[21] Frederick Wolfe,et al. Fatigue assessments in rheumatoid arthritis: comparative performance of visual analog scales and longer fatigue questionnaires in 7760 patients. , 2004, The Journal of rheumatology.
[22] G. Mitchell,et al. Performance and Repeatability of the NEI-VFQ-25 in Patients With Dry Eye , 2002, Cornea.
[23] M. Liang,et al. Measurement of systemic lupus erythematosus activity in clinical research. , 1988, Arthritis and rheumatism.